Lexicon Pharmaceuticals (NASDAQ: LXRX) revenue
Lexicon Pharmaceuticals reported revenue of $49.8m for fiscal 2025, 60.2% more than in fiscal 2024 ($31.1m). Since fiscal 2016 its revenue has fallen by 37.2%, an average decline of 5.0% a year.
Lexicon Pharmaceuticals has grown its revenue for 3 years in a row, and its best year of the last 10 was fiscal 2019. The biggest drop was in fiscal 2021, −98.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $49.8m | +60.2% | −$48.9m | −98.2% |
| 2024 | $31.1m | +2,481.5% | −$197.1m | −634.2% |
| 2023 | $1.2m | +766.2% | −$171.8m | −14,265.0% |
| 2022 | $0.1m | −53.4% | −$100.8m | −72,489.2% |
| 2021 | $0.3m | −98.8% | −$87.1m | −29,224.8% |
| 2020 | $24.0m | −92.5% | −$47.8m | −199.2% |
| 2019 | $322.1m | +409.5% | $141.4m | 43.9% |
| 2018 | $63.2m | −31.1% | −$103.3m | −163.4% |
| 2017 | $91.7m | +15.7% | −$130.6m | −142.5% |
| 2016 | $79.3m | — | −$127.2m | −160.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Lexicon Pharmaceuticals revenue compared with its sector
By revenue for its latest fiscal year, Lexicon Pharmaceuticals ranks 328th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Lexicon Pharmaceuticals, 60.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 326th | Protalix Biotherapeutics | $52.7m | −1.2% |
| 327th | Ocular Therapeutix | $52.0m | −18.5% |
| 328th | Lexicon Pharmaceuticals | $49.8m | 60.2% |
| 329th | Protagonist Therapeutics | $46.0m | −89.4% |
| 330th | Septerna | $46.0m | 4,174.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Lexicon Pharmaceuticals
- How much revenue did Lexicon Pharmaceuticals make in fiscal 2025?
- Lexicon Pharmaceuticals reported revenue of $49.8m for fiscal 2025, compared with $31.1m in fiscal 2024.
- How much has the revenue of Lexicon Pharmaceuticals fallen?
- Between fiscal 2016 and fiscal 2025 it went from $79.3m to $49.8m: 37.2% less, an average decline of 5.0% a year.
- What was the best year for revenue at Lexicon Pharmaceuticals?
- Of its last 10 fiscal years, fiscal 2019, with $322.1m.
- Where does Lexicon Pharmaceuticals rank in its sector by revenue?
- It ranks 328th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Lexicon Pharmaceuticals come from?
- From the annual report (Form 10-K) that Lexicon Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Lexicon Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Lexicon Pharmaceuticals: the Lexicon Pharmaceuticals page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.